Haploidentical Hematopoietic Stem Cell Transplantation in a Myelofibrosis Patient with Primary Graft Failure

Overview

Journal Hematol Rep

Publisher MDPI

Date 2018 Feb 1

PMID 29383224

Authors

Cristina Tecchio

Angelo Andreini

Claudio Costantini

Alberto Zamo

Donata de Sabata

Fiorenza Aprili

Roberta Galavotti

Emanuele Guardalben

Fabio Benedetti

Affiliations

Soon will be listed here.

References

Yoshihara S, Ikegame K, Taniguchi K, Kaida K, Kim E, Nakata J . Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning. Bone Marrow Transplant. 2011; 47(3):369-73. DOI: 10.1038/bmt.2011.84. View

Perini G, Kerbauy F, Fernandes J, Santos F, Torres M, Ribeiro A . Haploidentical non-myeloablative stem cell transplantation as salvage for graft failure in a patient with juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2011; 57(6):1084. DOI: 10.1002/pbc.23163. View

Cervantes F . How I treat myelofibrosis. Blood. 2014; 124(17):2635-42. DOI: 10.1182/blood-2014-07-575373. View

Fuji S, Nakamura F, Hatanaka K, Taniguchi S, Sato M, Mori S . Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell.... Biol Blood Marrow Transplant. 2012; 18(9):1407-14. DOI: 10.1016/j.bbmt.2012.02.014. View

Passamonti F, Cervantes F, Vannucchi A, Morra E, Rumi E, Pereira A . A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood. 2009; 115(9):1703-8. DOI: 10.1182/blood-2009-09-245837. View

Kanda J, Horwitz M, Long G, Gasparetto C, Sullivan K, Chute J . Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2011; 47(5):700-5. PMC: 3214602. DOI: 10.1038/bmt.2011.158. View

Moscardo F, Romero S, Sanz J, Sanz M, Montesinos P, Lorenzo I . T cell-depleted related HLA-mismatched peripheral blood stem cell transplantation as salvage therapy for graft failure after single unit unrelated donor umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2014; 20(7):1060-3. DOI: 10.1016/j.bbmt.2014.03.024. View

Cervantes F, Dupriez B, Pereira A, Passamonti F, Reilly J, Morra E . New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood. 2008; 113(13):2895-901. DOI: 10.1182/blood-2008-07-170449. View

Gupta V, Gotlib J, Radich J, Kroger N, Rondelli D, Verstovsek S . Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis. Biol Blood Marrow Transplant. 2014; 20(9):1274-81. PMC: 4465357. DOI: 10.1016/j.bbmt.2014.03.017. View

10.

Pagliuca S, Legendre H, Morin S, Rabian F, Naveau L, Zine M . Success of haploidentical hematopoietic stem cells transplantation in the treatment of graft failure. Ann Hematol. 2015; 95(2):353-4. DOI: 10.1007/s00277-015-2525-6. View

11.

Sorror M, Maris M, Storb R, Baron F, Sandmaier B, Maloney D . Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005; 106(8):2912-9. PMC: 1895304. DOI: 10.1182/blood-2005-05-2004. View

12.

Kroger N, Kvasnicka M, Thiele J . Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis. Fibrogenesis Tissue Repair. 2012; 5(Suppl 1):S25. PMC: 3368753. DOI: 10.1186/1755-1536-5-S1-S25. View

13.

Thiele J, Kvasnicka H, Facchetti F, Franco V, van der Walt J, Orazi A . European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005; 90(8):1128-32. View

14.

Olsson R, Logan B, Chaudhury S, Zhu X, Akpek G, Bolwell B . Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 2015; 29(8):1754-62. PMC: 4527886. DOI: 10.1038/leu.2015.75. View

15.

Bregante S, Dominietto A, Ghiso A, Raiola A, Gualandi F, Varaldo R . Improved Outcome of Alternative Donor Transplantations in Patients with Myelofibrosis: From Unrelated to Haploidentical Family Donors. Biol Blood Marrow Transplant. 2015; 22(2):324-329. DOI: 10.1016/j.bbmt.2015.09.028. View

16.

Park J, Koh K, Choi E, Jang S, Kwon S, Park C . Successful rescue of early graft failure in pediatric patients using T-cell-depleted haploidentical hematopoietic SCT. Bone Marrow Transplant. 2013; 49(2):270-5. DOI: 10.1038/bmt.2013.163. View

17.

Tefferi A, Vannucchi A . Genetic Risk Assessment in Myeloproliferative Neoplasms. Mayo Clin Proc. 2017; 92(8):1283-1290. DOI: 10.1016/j.mayocp.2017.06.002. View

18.

Kroger N, Deeg J, Olavarria E, Niederwieser D, Bacigalupo A, Barbui T . Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group. Leukemia. 2015; 29(11):2126-33. DOI: 10.1038/leu.2015.233. View

19.

Luznik L, ODonnell P, Symons H, Chen A, Leffell M, Zahurak M . HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008; 14(6):641-50. PMC: 2633246. DOI: 10.1016/j.bbmt.2008.03.005. View

20.

Tang B, Zhu X, Zheng C, Liu H, Geng L, Wang X . Successful early unmanipulated haploidentical transplantation with reduced-intensity conditioning for primary graft failure after cord blood transplantation in hematologic malignancy patients. Bone Marrow Transplant. 2014; 50(2):248-52. DOI: 10.1038/bmt.2014.250. View